108 related articles for article (PubMed ID: 4005274)
1. In vitro conversion of phytol to phytanic acid in rat liver: subcellular distribution of activity and chemical characterization of intermediates using a new bromination technique.
Muralidharan FN; Muralidharan VB
Biochim Biophys Acta; 1985 Jun; 835(1):36-40. PubMed ID: 4005274
[TBL] [Abstract][Full Text] [Related]
2. Characterization of phytol-phytanate conversion activity in rat liver.
Muralidharan FN; Muralidharan VB
Biochim Biophys Acta; 1986 Aug; 883(1):54-62. PubMed ID: 3730426
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the final step in the conversion of phytol into phytanic acid.
van den Brink DM; van Miert JN; Dacremont G; Rontani JF; Wanders RJ
J Biol Chem; 2005 Jul; 280(29):26838-44. PubMed ID: 15866875
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of long-chain isoprenoid alcohols. Incorporation of phytol and dihydrophytol into the lipids of rat brain.
Su KL; Schmid HH
Biochim Biophys Acta; 1975 Jan; 380(1):119-26. PubMed ID: 1122306
[TBL] [Abstract][Full Text] [Related]
5. Identification of fatty aldehyde dehydrogenase in the breakdown of phytol to phytanic acid.
van den Brink DM; van Miert JN; Dacremont G; Rontani JF; Jansen GA; Wanders RJ
Mol Genet Metab; 2004 May; 82(1):33-7. PubMed ID: 15110319
[TBL] [Abstract][Full Text] [Related]
6. Evidence against alpha-hydroxyphytanic acid as an intermediate in the metabolism of phytanic acid.
Skjeldal OH; Stokke O
Scand J Clin Lab Invest; 1988 Feb; 48(1):97-102. PubMed ID: 2464193
[TBL] [Abstract][Full Text] [Related]
7. Deuterium nuclear magnetic resonance study of the interaction of branched chain compounds (phytanic acid, phytol) with a phospholipid model membrane.
Yue J; Thewalt JL; Cushley RJ
Chem Phys Lipids; 1988 Dec; 49(3):205-13. PubMed ID: 3240564
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of phytol-U-14C and phytanic acid-U-14C in the rat.
Mize CE; Avigan J; Baxter JH; Fales HM; Steinberg D
J Lipid Res; 1966 Sep; 7(5):692-7. PubMed ID: 5971048
[TBL] [Abstract][Full Text] [Related]
9. Disorders related to the metabolism of phytanic acid.
Stokke O; Skjeldal OH; Høie K
Scand J Clin Lab Invest Suppl; 1986; 184():3-10. PubMed ID: 2438746
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial oxidation of phytanic acid in human and monkey liver: implication that Refsum's disease is not a peroxisomal disorder.
Watkins PA; Mihalik SJ
Biochem Biophys Res Commun; 1990 Mar; 167(2):580-6. PubMed ID: 1690986
[TBL] [Abstract][Full Text] [Related]
11. Effects of dietary phytol and phytanic acid in animals.
Steinberg D; Avigan J; Mize CE; Baxter JH; Cammermeyer J; Fales HM; Highet PF
J Lipid Res; 1966 Sep; 7(5):684-91. PubMed ID: 4165840
[TBL] [Abstract][Full Text] [Related]
12. The subcellular localization of phytanic acid oxidase in rat liver.
Skjeldal OH; Stokke O
Biochim Biophys Acta; 1987 Sep; 921(1):38-42. PubMed ID: 3620488
[TBL] [Abstract][Full Text] [Related]
13. 3-Methyladipate excretion in animals fed a phytol supplement with reference to Refsum's disease.
Krywawych S; Brenton DP; Jackson MJ; Forte C; Walker DK; Lawson AM
J Inherit Metab Dis; 1985; 8 Suppl 2():147-8. PubMed ID: 2413274
[No Abstract] [Full Text] [Related]
14. Phytanic acid alpha-oxidation in rat liver. Requirement of cytosolic factor.
Muralidharan VB; Kishimoto Y
J Biol Chem; 1984 Nov; 259(21):13021-6. PubMed ID: 6238033
[TBL] [Abstract][Full Text] [Related]
15. Phytol metabolites are circulating dietary factors that activate the nuclear receptor RXR.
Kitareewan S; Burka LT; Tomer KB; Parker CE; Deterding LJ; Stevens RD; Forman BM; Mais DE; Heyman RA; McMorris T; Weinberger C
Mol Biol Cell; 1996 Aug; 7(8):1153-66. PubMed ID: 8856661
[TBL] [Abstract][Full Text] [Related]
16. Phytol/Phytanic acid and insulin resistance: potential role of phytanic acid proven by docking simulation and modulation of biochemical alterations.
Elmazar MM; El-Abhar HS; Schaalan MF; Farag NA
PLoS One; 2013; 8(1):e45638. PubMed ID: 23300941
[TBL] [Abstract][Full Text] [Related]
17. Peroxisomal trans-2-enoyl-CoA reductase is involved in phytol degradation.
Gloerich J; Ruiter JP; van den Brink DM; Ofman R; Ferdinandusse S; Wanders RJ
FEBS Lett; 2006 Apr; 580(8):2092-6. PubMed ID: 16546181
[TBL] [Abstract][Full Text] [Related]
18. Phytanic acid: production from phytol, its breakdown and role in human disease.
van den Brink DM; Wanders RJ
Cell Mol Life Sci; 2006 Aug; 63(15):1752-65. PubMed ID: 16799769
[TBL] [Abstract][Full Text] [Related]
19. Assay for Sjögren-Larsson syndrome based on a deficiency of phytol degradation.
van den Brink DM; van Miert JM; Wanders RJ
Clin Chem; 2005 Jan; 51(1):240-2. PubMed ID: 15613721
[No Abstract] [Full Text] [Related]
20. Infantile phytanic acid storage disease, a possible variant of Refsum's disease: three cases, including ultrastructural studies of the liver.
Scotto JM; Hadchouel M; Odievre M; Laudat MH; Saudubray JM; Dulac O; Beucler I; Beaune P
J Inherit Metab Dis; 1982; 5(2):83-90. PubMed ID: 6188882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
